Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 539 | 370 | 148 | 44 | 157 |
| Gross Profit | 539 | 370 | 148 | 44 | 157 |
| Operating Expenses | 115,082 | 108,131 | 92,547 | 80,733 | 73,743 |
| Operating Income | -114,543 | -107,761 | -92,399 | -80,689 | -73,586 |
| Other Income | 1,955 | 575 | 160 | 1,412 | 4,232 |
| Pre-tax Income | -112,588 | -107,186 | -92,239 | -79,277 | -69,354 |
| Income Tax | 575 | -147 | 200 | 379 | 377 |
| Net Income Continuous | -113,163 | -107,039 | -92,439 | -79,656 | -69,731 |
| Net Income | $-113,163 | $-107,039 | $-92,439 | $-79,656 | $-69,731 |
| EPS Basic Total Ops | -1.51 | -1.52 | -1.32 | -1.30 | -1.15 |
| EPS Basic Continuous Ops | -1.51 | -1.53 | -1.32 | -1.30 | -1.15 |
| EPS Diluted Total Ops | -1.51 | -1.52 | -1.32 | -1.30 | -1.15 |
| EPS Diluted Continuous Ops | -1.51 | -1.53 | -1.32 | -1.30 | -1.15 |
| EBITDA(a) | $-111,828 | $-103,338 | $-90,064 | $-78,497 | $-71,495 |